statistiche ricercatore

Nome	#
Transglutaminase type 2-dependent selective recruitment of proteins into exosomes under stressful cellular conditions.	385
ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells	372
Human immunodeficiency virus-induced cell death in cytokine-treated macrophages can be prevented by compounds that inhibit late stages of viral replication	370
Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection	297
TG2 regulates the heat-shock response by the post-translational modification of HSF1.	295
Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2.	260
Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis	39
Type 2 Transglutaminase, mitochondria and Huntington's disease: menage a trois	32
ZFP750 affects the cutaneous barrier through regulating lipid metabolism	15
Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants	9
Cysteamine with in vitro antiviral activity and immunomodulatory effects has the potential to be a repurposing drug candidate for covid-19 therapy	7
Transglutaminase 2 ablation leads to mitophagy impairment associated with a metabolic shift towards aerobic glycolysis	6
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection	4
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma	3
Totale	2.094

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	136	0	0	0	0	0	0	0	0	0	0	72	64
2019/2020	638	51	45	37	63	53	69	56	55	69	46	48	46
2020/2021	379	49	45	43	40	37	43	41	50	11	7	11	2
2021/2022	86	8	6	0	3	1	10	8	10	3	5	11	21
2022/2023	139	10	18	1	19	20	21	13	9	15	0	3	10
2023/2024	76	13	5	5	3	10	15	0	1	10	12	2	0
Totale													2.094